10-K annual report · filed Feb 11, 2026

Johnson & Johnson (JNJ) FY2025 10-K Annual Report

Short answer

Johnson & Johnson (JNJ) filed its fiscal 2025 10-K annual report with the SEC on Feb 11, 2026. It reported revenue of $94.2B (+6.0% year over year) and net income of $26.8B.

  • Top risk flagged: Board Regulatory Compliance & Sustainability Committee oversees cybersecurity risk and compliance with privacy laws

FY2025 key financial metrics · XBRL

Revenue
$94.2B
+6.0% YoY
Net income
$26.8B
+90.6% YoY
Gross margin
67.9%
−1.2 pp YoY
EPS (diluted)
$11.03
+90.5% YoY
ROE
32.9%
+13.2 pp YoY
Operating cash flow
$24.5B
+1.1% YoY

Source: XBRL data from the Johnson & Johnson (JNJ) FY2025 10-K on SEC EDGAR. USD.

Johnson & Johnson FY2025 10-K analysis

AI summary of each section, grounded in the filing text

Business Overview

  • Core business model not detailed; filing focuses on corporate governance and compliance policies
  • New emphasis on transparency with online posting of Code of Business Conduct amendments and waivers within five business days
  • Strengthened insider trading policy for directors, officers, and certain insiders to ensure compliance with laws and listing standards
  • Unusual focus on detailed disclosure of corporate governance codes and ethical standards rather than product or market information

Management Discussion & Analysis

  • Revenue $94.2B in 2025, up 6.0% YoY from $88.8B in 2024; U.S. sales $53.8B (+6.9%), international $40.4B (+5.0%)
  • Operating margin 34.6% in 2025 vs 18.8% in 2024; Innovative Medicine margin 36.9% vs 33.2%; MedTech margin 12.2% vs 11.7%
  • Best segment: Innovative Medicine sales $60.4B (+6.0%), worst: Infectious Diseases sales $3.2B (-4.6%)
  • Cash/cash equivalents $20.1B end 2025; total debt $47.9B; acquisitions funded with senior notes; restructuring costs $205M (Surgery), $307M (Orthopaedics)
  • Risks: biosimilar competition impacting STELARA; expected generic competition for OPSUMIT in 2026; planned Orthopaedics separation in 18-24 months

Risk Factors

  • Board Regulatory Compliance & Sustainability Committee oversees cybersecurity risk and compliance with privacy laws
  • CISO provides quarterly updates on evolving cybersecurity threats and incidents impacting the company and industry
  • CIO and CISO responsible for cybersecurity incident detection, response, and recovery with 25+ years CISO experience
  • Cybersecurity risk management integrated into overall risk framework, with emphasis on threats relevant to 2026 landscape

Generated from the filing text; verify against the original. How to read a 10-K

Ask about this 10-K

Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.